← Back to headlines
CSL Signs Licensing Deal with Eli Lilly for Kidney Disease Treatment
CSL has entered into a licensing agreement with Eli Lilly for clazakizumab, a treatment for kidney disease.
17 Feb, 21:26 — 17 Feb, 21:26
Sources
Showing 1 of 1 sources
Related Stories
Amazon's First Customer Receipt Goes Viral, Bezos and Musk React
just now
Philippines Energy Secretary Confirms Diesel Cargo Arrival Amid Petronas Denial
just now
Philippine President Marcos Urges Unity, Warns Against Hoarding Amid Energy Crisis
just now
Marcos to decide on fuel excise tax cut or suspension by April 13
just now